Tempest Therapeutics (TPST) Return on Equity [ROE] (2012 - 2026)
Tempest Therapeutics (TPST) posted Return on Equity [ROE] of -740.27% for Q2 2026, down 328.15 percentage points from -412.12% a year earlier.
Powered by 
Analysis
Tempest Therapeutics (TPST) Return on Equity [ROE] (2012 - 2026) Analysis & Trends
For FY2025, Tempest Therapeutics' Return on Equity [ROE] came in at -203.63%, down 21.28 percentage points from FY2024.
- Annual Return on Equity [ROE] shows a three-year change of -71.93 percentage points (FY2022 to FY2025).
- In prior years, Tempest Therapeutics' Return on Equity [ROE] was -182.35% in FY2024 (-50.92 pp), -131.42% in FY2023 (+0.27 pp) and -131.70% in FY2022.
- The Q2 2026 figure stands as the lowest quarterly Return on Equity [ROE] since Q3 2023.
- On a year-over-year basis, Return on Equity [ROE] increased in 1 of the last seven quarters, with an average year-over-year change of +37.98 percentage points.
- The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q3 2024, with a gain of 1377.57 percentage points; the weakest was Q3 2023, with a drop of 1516.28 percentage points.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 74.39% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 19.33% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 5.63% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 21.60% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 72.13% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -31.17% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 4.66% |
| 10 | Tempest Therapeutics | 5.91 Mn | -11.91 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -1,150.81% |
| Dec 31, 2025 | -403.60% |
| Sep 30, 2025 | -447.07% |
| Jun 30, 2025 | -412.12% |
| Mar 31, 2025 | -296.10% |
| Dec 31, 2024 | -273.64% |
| Sep 30, 2024 | -250.16% |
| Jun 30, 2024 | -169.00% |
| Mar 31, 2024 | -125.57% |
| Dec 31, 2023 | -230.60% |
| Sep 30, 2023 | -1,627.73% |
| Jun 30, 2023 | -416.44% |
| Mar 31, 2023 | -239.74% |
| Dec 31, 2022 | -159.12% |
| Sep 30, 2022 | -111.45% |
| Jun 30, 2022 | -104.37% |
| Mar 31, 2022 | -96.03% |
| Sep 30, 2021 | -1,085.32% |
| Sep 30, 2019 | -83.58% |
| Jun 30, 2019 | -64.00% |
API Access
Tempest Therapeutics Return on Equity [ROE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TPST&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-equity-[roe]", "ticker": "TPST", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TPST&period=max&api_key=YOUR_API_KEY");
const data = await res.json();